Lumexa Imaging Holdings: Capitalizing on Outpatient Imaging Tailwinds with Sustainable Growth and Attractive Risk-Reward
I'm PortAI, I can summarize articles.
Stephen Baxter from Wells Fargo has initiated a Buy rating on Lumexa Imaging Holdings (LMRI), citing its strong strategic positioning in the outpatient imaging sector. The company is benefiting from a shift towards lower-cost imaging centers and has a significant presence in states like Texas and North Carolina. Baxter highlights Lumexa's joint ventures with hospital systems, particularly with Baylor Scott & White Health, as key to its growth. He projects mid- to high-single-digit EBITDA growth and sets a price target of $22. Jefferies also initiated coverage with a Buy rating and a $23 target.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments